Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sonali Smith
University of Chicago Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Central Illinois Hematology Oncology Center
Springfield, Illinois, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
- Fort Wayne Medical Oncology and Hematology Inc-Parkview
Fort Wayne, Indiana, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- Mercy Hospital Saint Louis
St Louis, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Apr 2010
- Primary completion
- 31 Dec 2017
- Completion
- 30 Sept 2018
- Last update posted
- 16 Oct 2019
- Registered enrollment
- 110
- Registry id
- NCT01076543
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.